Protective effect of thymoquinone against doxorubicin-induced cardiotoxicity in rats: A possible mechanism of protection

被引:233
|
作者
Nagi, MN [1 ]
Mansour, MA [1 ]
机构
[1] King Saud Univ, Coll Pharm, Dept Pharmacol, Riyadh 11451, Saudi Arabia
关键词
thymoquinone; lactate dehydrogenase; creatine phosphokinase; cardiotoxicity; doxorubicin;
D O I
10.1006/phrs.1999.0585
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Administration of thymoquinone (10 mg kg(-1) day(-1), p.o.) with drinking water starting 5 days before a single injection of doxorubicin (15 mg kg(-1) i.p.) and continuing during the experimental period ameliorated the doxorubicin-induced cardiotoxicity in rats. This protection was evidenced from the significant reduction in serum enzymes: lactate dehydrogenase elevated level, 24 h and creatine phosphokinase elevated levels, 24 h and 48 h after doxorubicin administration. The cardiotoxicity of doxorubicin has been suggested to result from the generation of superoxide free-radical. The protective action of thymoquinone was examined against superoxide anion radical either generated photochemically, biochemically or derived from calcium ionophore (A23187) stimulated polymorphonuclear leukocytes. The results indicate that thymoquinone is a potent superoxide radical scavenger, scavenging power being as effective as superoxide dismutase against superoxide. In addition thy moquinone has an inhibitory effect on lipid peroxidation induced by Fe3+/ascorbate using rat heart homogenate. The superoxide scavenging and anti-lipid peroxidation may explain, in part, the protective effect of thymoquinone against doxorubicin-induced cardiotoxicity. (C) 2000 Academic Press.
引用
收藏
页码:283 / 289
页数:7
相关论文
共 50 条
  • [1] Protective effect of thymoquinone against doxorubicin-induced cardiotoxicity and the underlying mechanism
    Chen, Yi
    Luo, Wei
    Wu, Yanqing
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2025, 495
  • [2] The Protective Effect of Citronellol against Doxorubicin-Induced Cardiotoxicity in Rats
    Munir, Sania
    Hafeez, Rizwan
    Younis, Waqas
    Malik, Muhammad Nasir Hayat
    Munir, Muhammad Usman
    Manzoor, Wajiha
    Razzaq, Muryam Abdul
    Pessoa, Luciane Barbosa
    Lopes, Katiana Simoes
    Livero, Francislaine Aparecida dos Reis
    Gasparotto Jr, Arquimedes
    BIOMEDICINES, 2023, 11 (10)
  • [3] Protective effect of tetrandrine on doxorubicin-induced cardiotoxicity in rats
    Xu, Meng
    Sheng, Lianghe
    Zhu, Xinhai
    Zeng, Shibin
    Chi, Dexiang
    Zhang, Guo-jun
    TUMORI, 2010, 96 (03) : 460 - 464
  • [4] Protective effect of nebivolol on doxorubicin-induced cardiotoxicity in rats
    Mohamed, Enas Ahmed
    Kassem, Hussien H.
    ARCHIVES OF MEDICAL SCIENCE, 2018, 14 (06) : 1450 - 1458
  • [5] Protective effect of arabic gum against cardiotoxicity induced by doxorubicin in mice: A possible mechanism of protection
    Abd-Allah, ARA
    Al-Majed, AA
    Mostafa, AM
    Al-Shabanah, OA
    El Din, AG
    Nagi, MN
    JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY, 2002, 16 (05) : 254 - 259
  • [6] Protective effect of Spirulina against doxorubicin-induced cardiotoxicity
    Khan, M
    Shobha, JC
    Mohan, IK
    Naidu, MUR
    Sundaram, C
    Singh, S
    Kuppusamy, P
    Kutala, VK
    PHYTOTHERAPY RESEARCH, 2005, 19 (12) : 1030 - 1037
  • [7] Protective effect of silymarin on doxorubicin-induced cardiotoxicity in rats
    Nebojša Stilinović
    Aleksandar Rašković
    Momir Mikov
    Saša Vukmirović
    Boris Milijašević
    BMC Pharmacology and Toxicology, 13 (Suppl 1)
  • [8] Protective Effect of Edaravone on Doxorubicin-Induced Cardiotoxicity in Rats
    Aygun, Hatice
    Gul, Serdar Savas
    ACTA PHYSIOLOGICA, 2018, 225 : 27 - 27
  • [9] The effects of melatonin and thymoquinone on doxorubicin-induced cardiotoxicity in rats
    Pehlivan, Yildiz D.
    Durdagi, G.
    Oyar, Oz E.
    Akyol, S.
    Ozbek, M.
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2020, 121 (10): : 753 - 759
  • [10] Potential protective effect of pitavastatin against doxorubicin-induced cardiotoxicity in male rats
    Al-Chlaihawi, Mohammed K.
    Janabi, Ali M.
    JOURNAL OF POPULATION THERAPEUTICS AND CLINICAL PHARMACOLOGY, 2023, 30 (08): : E338 - E348